Lansoprazole Capsule, Delayed Release
Product Images NDC 70756-807

The text describes a chart that shows the mean severity of day heartburn over several days of treatment for three groups of patients. The severity was measured on a 4-point scale (from severe to none). One group received a placebo, the second group received 15 mg of lansoprazole, and the third group received 30 mg of lansoprazole. The chart shows that the severity of day heartburn decreased over time for all groups, but the decrease was more pronounced for the groups receiving lansoprazole.*

This is a graph showing the mean severity of night heartburn by study day for evaluable patients. The severity of heartburn is measured on a scale of 0 (none) to 3 (severe). The study compares the effects of a placebo, lansoprazole 15 mg QD, and lansoprazole 30 mg QD. The x-axis represents the days from the start of treatment, and the y-axis represents the mean severity of heartburn.*

This is a bottle of Lansoprazole delayed-release capsules, USP with 30 capsules each containing 15 mg of lansoprazole as enteric-coated pellets. The medication guide accompanying it should be given to each patient. It is for prescription use only and should be kept in a tight container out of reach of children. The capsules are imprinted with the words "utestr'c" and "806" for product identification. The capsules should not be accepted if the seal over the bottle opening is broken or missing. The full prescribing information can be found in the enclosure. They should be stored at 25°C with excursions permitted at 15-30°C. The manufacturing company is Inventia Healthcare Limited based in India and is manufactured for Lifestar Pharma LLC based in Mahwah, NJ, USA. The Lot number is HOBO0KHK and was manufactured on 3004, 30004 with an expiration date of 30040000.*

This is a bottle of Lansoprazole Delayed-Release Capsules, USP, containing 30 capsules. Each capsule contains 30mg of lansoprazole USP as enteric-coated pellets. The bottle has an NDC label, and the capsules are dispensed by Pharmagist. There is a medication guide included for each patient, and the capsules are Rx only. Each capsule is imprinted with "Litestrt" and "807." The full prescribing information is included in the enclosure. The capsules should be stored in a USP tight container at 25°C (77°F) with excursions permitted 10-15°C (59-86°F) [See USP Controlled Room Temperature]. The product is of Indian origin, and it is manufactured by Inventia Healthcare Limited, Additional Ambernath M.LD.C., Ambernath (East) - 421506, INDIA, before being sold to Lifestar Pharma LG in Mahweh, NJ, USA.*